Sort by
Refine Your Search
-
Category
-
Employer
-
Field
-
Carl von Ossietzky University of Oldenburg • | Oldenburg Oldenburg, Niedersachsen | Germany | 3 days ago
/content The Joint Research Academy in Biomedical Engineering and Science of Hearing and Sensory Systems (JRA) is a joint project of the University of Oldenburg, Hannover Medical School and Leibniz
-
of the tumor suppressor p53, which upregulates the cyclin-dependent kinase (CDK) inhibitor p21. In this project, we aim to investigate the crosstalk between mitotic timing and G1 arrest using engineered cell
-
& regeneration, and biomedical technology & implants. These research priorities reflect our major clinical strengths, producing numerous innovations in the search for novel treatment options based on chemical
-
Engineering, Physiology and Therapy of Hearing “Auditory Sciences” is a structured PhD programme that is integrated in the “Joint Research Academy in Biomedical Engineering and Science of Hearing and Sensory
-
, biomedical diagnostics in the life sciences, energy-efficient lighting and solar energy harvesting. This is reflected in the fact that the average annual growth of the optics and photonics market has exceeded
-
biomedical engineering, bioinformatics, biotechnology, molecular imaging and biomaterials. Training within the RegSci PhD programme takes place across three levels: students carry out their own research
-
researchers from around the world. We offer a wide range of career opportunities in science, technology, and administration. Organic light-emitting diodes (OLEDs) are a popular class of semiconductor devices
-
None Combined Master's degree / PhD programme No Joint degree / double degree programme No Description/content Based on a biomedical Master's course of study, the aim of the doctoral course of study
-
: Master’s degree or equivalent in Neuroscience, Biology, Biomedical engineering, Life sciences, or a related field Experience with electrophysiological recording or neuroimaging would be beneficial
-
disciplines ranging from interface and macromolecular chemistry to drug delivery and cancer therapy technology and seeks to make significant contributions to both fundamental science and practical applications